does microdosing tirzepatide work for weight loss and metabolic health 𝗪𝐡𝐲 𝐰𝐞 𝐥𝐨𝐯𝐞 𝐦𝐢𝐜𝐫𝐨-𝐝𝐨𝐬𝐢𝐧𝐠 𝐓𝐢𝐫𝐳𝐞𝐩𝐚𝐭𝐢𝐝𝐞/𝐒𝐞𝐦𝐚𝐠𝐥𝐮𝐭𝐢𝐝𝐞

As proof of concept that PCSK9/GLP-1 peptide-antibody molecules can deliver dual pharmacology, we investigated a panel of N-terminal genetic fusions of a DPP-4-resistant GLP-1 analogue with different PCSK9 antibodies and linkers

7 Prevalence and duration of gastrointestinal events by severity

The researchers concluded that semaglutide was well tolerated over 52 weeks when used in conjunction with dietary and exercise counseling and demonstrated clinically meaningful weight loss as compared to placebo at all doses

Before starting, expect your provider to review baseline metabolic bloodwork, assess medication interactions, and establish realistic timelines